Highlights:
·
It is SARS-CoV-2 Antigen Self-Test Nasal for
at-home testing.
·
Individuals can perform the test at home using a
nasal swab without special training.
·
Requiring a sample from the lower part of both
nostrils.
·
The test provides results in as little as 15 minutes.
·
Easy and less uncomfortable to perform.
·
Available in a pack of five tests.
·
Roche is offering NAVIFY Pass as a complementary.
As the world prepares to reopen,
high-quality, home-based testing will play an important role in the battle
against the pandemic. Regular self-testing at home can reduce pressure on
healthcare systems.
Roche has received the CE mark
for its SARS-CoV-2 Antigen Self-Test Nasal for at-home testing. This
test is part of a partnership with SD Biosensor and has received
official approval following the traditional registration pathway and can now
also be used in markets that have not established regulatory exemption
pathways. Individuals can perform the test at home using a nasal swab without
special training or the supervision of a healthcare worker. The test provides
results in as little as 15 minutes and can help people to check if they are
likely to be infectious from home.
Complementary to the SARS-CoV-2 Antigen Self-Test Nasal, Roche is offering NAVIFY Pass. This digital solution allows individuals and healthcare professionals to remotely store, display, and share their COVID-19 test results and vaccine status through a personalized QR code. Having easy digital access to test results and vaccination status could potentially be used by both individuals and companies to facilitate access to locations with COVID-19 entry protocols, such as restaurants or entertainment venues, as well as to validate safety to travel. For more information on NAVIFY Pass, Read more
Comments
Post a Comment